Format

Send to

Choose Destination
JRSM Cardiovasc Dis. 2012 Nov 30;1(8):2048004012474754. doi: 10.1177/2048004012474754.

Cerebral microbleeds: a new dilemma in stroke medicine.

Author information

1
Department of Stroke Medicine, Imperial College Healthcare NHS Trust , London W6 8RF , UK.

Abstract

Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase in the risk of intracerebral haemorrhage (ICH), the most feared complication in patients treated with thrombolytic or antithrombotic (antiplatelet and anticoagulant) drugs. This review will summarize the evidence available regarding CMBs as an indicator of future ICH risk in stroke medicine clinical practice.

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center